Publications Database

Hardan A. Y. et al. (2012)

A randomized controlled pilot trial of oral N-acetylcysteine in children with autism.

Biological Psychiatry

71(11), pp. 956-961.

Read Abstract (New Window)

Harfterkamp M. et al. (2012)

A randomized double-blind study of atomoxetine versus placebo for attention-deficit/hyperactivity disorder symptoms in children with autism spectrum disorder.

Journal of the American Academy of Child and Adolescent Psychiatry

5(7), pp. 733-741.

Read Abstract (New Window)

Harfterkamp M. et al. (2013)

Long-term treatment with atomoxetine for attention-deficit/hyperactivity disorder symptoms in children and adolescents with autism spectrum disorder: An open-label extension study.

Journal of Child and Adolescent Psychopharmacology

23(3), pp. 194-199.

Read Abstract (New Window)

Hellings J. A. et al. (2001)

Weight gain in a controlled study of risperidone in children, adolescents and adults with mental retardation and autism.

Journal of Child and Adolescent Psychopharmacology

11(3), pp. 229-238

Read Abstract (New Window)

Hildebrandt M. K. , Koch S. C. , Fuchs T. (2016)

We dance and find each other: Effects of dance-movement therapy on negative symptoms in autism spectrum disorder.

Behavioral Sciences

November, 6(4), pii: E24.

Read Abstract (New Window)

Hollander E. et al. (2006)

A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorder

Journal of Child and Adolescent Psychopharmacology

16 pp. 541-548

Read Abstract (New Window)

Hollander E. et al. (2006)

Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorder.

International Journal of Neuropsycholpharmacology

9(2), pp. 209-213

Read Abstract (New Window)

Hollander E. et al. (2007)

Oxytocin increases retention of social cognition in autism.

Biological Psychiatry

61(4), pp. 498-503

Read Abstract (New Window) Read Full (New Window)

Hollander E. et al. (2003)

Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders

Neuropsychopharmacology

28 pp. 193-198

Read Abstract (New Window) Read Full (New Window)

Hyman S. L. et al. (2016)

The gluten-free, casein-free diet: a double-blind challenge trial in children with autism.

Journal of Autism and Developmental Disorders

January, 46(1), pp. 205-220.

Read Abstract (New Window)

Ichikawa H. et al.

Aripiprazole in the treatment of irritability in children and adolescents with autism spectrum disorder in Japan: A randomized, double-blind, placebo-controlled study.

Child Psychiatry and Human Development

Read Abstract (New Window)

Jiang L. , Wang M. , Tang X. (2017)

Levetiracetam is associated with decrease in subclinical epileptiform discharges and improved cognitive functions in pediatric patients with autism spectrum disorder.

Neuropsychiatric Disease and Treatment

13 pp. 2321–2326.

Read Abstract (New Window) Read Full (New Window)

Kaplan M. , Edelson S. M. , Seip J. (1999)

Behavioral changes in autistic individuals as a result of wearing ambient transitional prism lenses.

Child Psychiatry and Human Development

29(1), pp. 65-76

Read Abstract (New Window)

Kent J. M. et al. (2013)

Risperidone dosing in children and adolescents with autistic disorder: A double-blind, placebo-controlled study.

Journal of Autism and Developmental Disorders

43(8), pp. 1773-1783.

Read Abstract (New Window)

Kerley C. P. et al. (2017)

Lack of effect of vitamin D3 supplementation in autism: a 20-week, placebo-controlled RCT.

Archives of Disease in Childhood

November, 102(11), pp. 1030-1036.

Read Abstract (New Window)

Kern J. K. et al. (2001)

Effectiveness of N,N-dimethylglycine in autism and pervasive developmental disorder.

Journal of Child Neurology

16(3), pp. 169-173

Read Abstract (New Window)

Kern J. K. et al. (2002)

Efficacy of porcine secretin in children with autism and pervasive developmental disorder.

Journal of Autism and Developmental Disorders

32(3),

Read Abstract (New Window)

King B. H. et al. (2001)

Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder.

Journal of the American Academy of Child and Adolescent Psychiatry

40(6), pp. 658-665

Read Abstract (New Window)

Klaiman C. et al. (2013)

Tetrahydrobiopterin as a treatment for autism spectrum disorders: a double-blind, placebo-controlled trial.

Journal of Child and Adolescent Psychopharmacology

June, 23(5), pp. 320-328.

Read Abstract (New Window)

Kolmen B. K. et al. (1995)

Naltrexone in young autistic children: a double-blind, placebo-controlled crossover study.

Journal of the American Academy of Child and Adolescent Psychiatry

34(2), pp. 223-231

Read Abstract (New Window)